IQVIA艾昆纬：2025印度肺癌临床试验就绪度白皮书（英文版）

ung cancer remains the leading cause of cancer mortality worldwide, with nearly 2.5 million new cases and 1.8 million deaths recorded in 2022. In India alone, there were an estimated 80,000 new cases and 75,000 deaths, placing lung cancer among the country’s top five cancers. The introduction of the New Drugs and Clinical Trials Rules (NDCTR) 2019 has brought new predictability to approval timelines. Investments in infrastructure have created a network of more than sixty mapped, trial-ready l